EC Requests Opinion on DEHP Devices
The European Commission has asked the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) to provide an opinion on the potential health impacts caused by DEHP (di(2-ethylhexyl) phthalate)-containing medical devices.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.